CAH
Price
$118.30
Change
+$1.30 (+1.11%)
Updated
Dec 20, 04:59 PM (EDT)
39 days until earnings call
SHTDF
Price
$2.49
Change
-$0.06 (-2.35%)
Updated
Dec 20 closing price
Ad is loading...

CAH vs SHTDF

Header iconCAH vs SHTDF Comparison
Open Charts CAH vs SHTDFBanner chart's image
Cardinal Health
Price$118.30
Change+$1.30 (+1.11%)
Volume$28.81K
CapitalizationN/A
Sinopharm Group
Price$2.49
Change-$0.06 (-2.35%)
Volume$100
CapitalizationN/A
CAH vs SHTDF Comparison Chart
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. SHTDF commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a Hold and SHTDF is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (CAH: $118.28 vs. SHTDF: $2.49)
Brand notoriety: CAH and SHTDF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 410% vs. SHTDF: 11%
Market capitalization -- CAH: $27.26B vs. SHTDF: $9.79B
CAH [@Medical Distributors] is valued at $27.26B. SHTDF’s [@Medical Distributors] market capitalization is $9.79B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 1 FA rating(s) are green whileSHTDF’s FA Score has 1 green FA rating(s).

  • CAH’s FA Score: 1 green, 4 red.
  • SHTDF’s FA Score: 1 green, 4 red.
According to our system of comparison, SHTDF is a better buy in the long-term than CAH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 5 TA indicator(s) are bullish while SHTDF’s TA Score has 2 bullish TA indicator(s).

  • CAH’s TA Score: 5 bullish, 4 bearish.
  • SHTDF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CAH is a better buy in the short-term than SHTDF.

Price Growth

CAH (@Medical Distributors) experienced а +0.15% price change this week, while SHTDF (@Medical Distributors) price change was -2.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.86%. For the same industry, the average monthly price growth was +2.51%, and the average quarterly price growth was +147.05%.

Reported Earning Dates

CAH is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Medical Distributors (+0.86% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAH($27.3B) has a higher market cap than SHTDF($9.79B). CAH has higher P/E ratio than SHTDF: CAH (44.47) vs SHTDF (8.00). CAH YTD gains are higher at: 19.019 vs. SHTDF (0.000). SHTDF has higher annual earnings (EBITDA): 24.7B vs. CAH (1.89B). SHTDF has more cash in the bank: 43.5B vs. CAH (4.59B). CAH has less debt than SHTDF: CAH (4.72B) vs SHTDF (68.4B). SHTDF has higher revenues than CAH: SHTDF (521B) vs CAH (216B).
CAHSHTDFCAH / SHTDF
Capitalization27.3B9.79B279%
EBITDA1.89B24.7B8%
Gain YTD19.0190.000-
P/E Ratio44.478.00556%
Revenue216B521B41%
Total Cash4.59B43.5B11%
Total Debt4.72B68.4B7%
FUNDAMENTALS RATINGS
CAH vs SHTDF: Fundamental Ratings
CAH
SHTDF
OUTLOOK RATING
1..100
9350
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
4100
SMR RATING
1..100
9858
PRICE GROWTH RATING
1..100
4750
P/E GROWTH RATING
1..100
9354
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHTDF's Valuation (19) in the null industry is somewhat better than the same rating for CAH (57) in the Medical Distributors industry. This means that SHTDF’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Profit vs Risk Rating (4) in the Medical Distributors industry is significantly better than the same rating for SHTDF (100) in the null industry. This means that CAH’s stock grew significantly faster than SHTDF’s over the last 12 months.

SHTDF's SMR Rating (58) in the null industry is somewhat better than the same rating for CAH (98) in the Medical Distributors industry. This means that SHTDF’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Price Growth Rating (47) in the Medical Distributors industry is in the same range as SHTDF (50) in the null industry. This means that CAH’s stock grew similarly to SHTDF’s over the last 12 months.

SHTDF's P/E Growth Rating (54) in the null industry is somewhat better than the same rating for CAH (93) in the Medical Distributors industry. This means that SHTDF’s stock grew somewhat faster than CAH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHSHTDF
RSI
ODDS (%)
Bearish Trend 6 days ago
66%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
67%
Momentum
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
63%
Advances
ODDS (%)
Bullish Trend 3 days ago
66%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
49%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
57%
Bearish Trend 3 days ago
56%
View a ticker or compare two or three
Ad is loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMFX25.680.35
+1.38%
Carillon Scout Mid Cap C
BGLKX34.030.43
+1.28%
Baillie Gifford Long Term Global Gr K
VWUSX72.680.68
+0.94%
Vanguard US Growth Investor
BRSDX14.720.12
+0.82%
MFS Blended Research Small Cap Eq A
LGCYX16.750.12
+0.72%
Lord Abbett Global Equity I

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with COR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
+1.09%
COR - CAH
55%
Loosely correlated
+0.63%
MCK - CAH
48%
Loosely correlated
+0.09%
OMI - CAH
27%
Poorly correlated
-0.79%
SHTDF - CAH
12%
Poorly correlated
-2.35%
EDAP - CAH
6%
Poorly correlated
-0.23%
More

SHTDF and

Correlation & Price change

A.I.dvisor tells us that SHTDF and SHTDY have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHTDF and SHTDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHTDF
1D Price
Change %
SHTDF100%
-2.35%
SHTDY - SHTDF
19%
Poorly correlated
-0.71%
COR - SHTDF
17%
Poorly correlated
+0.63%
SHPMY - SHTDF
12%
Poorly correlated
N/A
CAH - SHTDF
12%
Poorly correlated
+1.09%
AHG - SHTDF
10%
Poorly correlated
+3.36%
More